Oncology Growth Drivers
Rising Cancer Incidence
Under-Equipped International Market
New Technology/Products/Upgrades
IMRT
IGRT
Stereotactic Treatments
Cost Effectiveness
Previous slide
Next slide
Back to first slide
View graphic version